$1.83
4.89% today
Nasdaq, Aug 22, 04:50 pm CET

Inotiv Inc Stock price

$1.74
+0.01 0.58% 1M
-2.32 57.14% 6M
-2.40 57.97% YTD
+0.14 8.75% 1Y
-18.89 91.57% 3Y
-2.97 63.06% 5Y
+0.39 28.89% 10Y
-4.06 70.00% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.07 4.19%

Key metrics

Basic
Market capitalization
$59.8m
Enterprise Value
$452.9m
Net debt
$393.1m
Cash
$6.2m
Shares outstanding
34.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.1 | 0.1
EV/Sales
0.9 | 0.9
EV/FCF
negative
P/B
0.4
Financial Health
Equity Ratio
21.8%
Return on Equity
-63.6%
ROCE
-6.5%
ROIC
-5.5%
Debt/Equity
2.8
Financials (TTM | estimate)
Revenue
$505.3m | $515.3m
EBITDA
$16.1m | $37.4m
EBIT
$-40.5m | $-25.9m
Net Income
$-79.0m | $-79.7m
Free Cash Flow
$-46.4m
Growth (TTM | estimate)
Revenue
0.9% | 5.0%
EBITDA
-29.2% | 529.9%
EBIT
-41.8% | 49.5%
Net Income
20.4% | 26.5%
Free Cash Flow
-552.2%
Margin (TTM | estimate)
Gross
23.3%
EBITDA
3.2% | 7.3%
EBIT
-8.0%
Net
-15.6% | -15.5%
Free Cash Flow
-9.2%
More
EPS
$-2.3
FCF per Share
$-1.3
Short interest
7.0%
Employees
2k
Rev per Employee
$240.0k
Show more

Is Inotiv Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Inotiv Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Inotiv Inc forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Inotiv Inc forecast:

Buy
78%
Hold
22%

Financial data from Inotiv Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
505 505
1% 1%
100%
- Direct Costs 387 387
3% 3%
77%
118 118
6% 6%
23%
- Selling and Administrative Expenses 96 96
5% 5%
19%
- Research and Development Expense - -
-
-
16 16
29% 29%
3%
- Depreciation and Amortization 57 57
10% 10%
11%
EBIT (Operating Income) EBIT -41 -41
42% 42%
-8%
Net Profit -79 -79
20% 20%
-16%

In millions USD.

Don't miss a Thing! We will send you all news about Inotiv Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inotiv Inc Stock News

Neutral
GlobeNewsWire
9 days ago
WEST LAFAYETTE, Ind., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief F...
Neutral
Seeking Alpha
15 days ago
Inotiv, Inc. (NASDAQ:NOTV ) Q3 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Beth A. Taylor - Senior VP of Finance & CFO John E.
Neutral
GlobeNewsWire
16 days ago
In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corrected. The corrected release follows:
More Inotiv Inc News

Company Profile

Inotiv, Inc. operates as a pharmaceutical development company, which engages in the provision of drug discovery, development services, and analytical instruments. The firm operates through the following business segments: Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing. The Research Products segment designs, develops, manufactures, and markets vivo sampling systems and accessories, physiology monitoring tools, liquid chromatography, and electrochemistry instruments platforms. The company was founded by Peter T. Kissinger in 1974 and is headquartered in West Lafayette, IN.

Head office United States
CEO Robert Leasure
Employees 2,026
Founded 1974
Website www.inotiv.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today